case_images: PMC9193224_01
case_images: Patient's PSA level. (A) The level of PSA reduction in each patient. The black line is the 2-week regimen; Red, green and blue are patients with 1H regimen. (B) Median reduction of PSA levels in patients with 1H regimen. The black line is the 2-week regimen; The red line is the patients with 1h regimen; The yellow areas are interquartile spacing.
case_images: fonc-12-878264-g001.jpg
case_images: PMC9193224_01_fonc-12-878264-g001.jpg
case_images: f1
case_images: Taking into account the half-life of PSA (about 3 days), newly generated PSA in the third day is only about 16% of the original ( Supplementary Figure 1 ).
case_images: Patient's LH level. (A) The level of LH change in each patient. The black line is the 2-week regimen; Red, green and blue are patients with 1H regimen. (B) Median changes of LH levels in patients with 1H regimen. The black line is the 2-week regimen; The red line is the patients with 1h regimen; The yellow areas are interquartile spacing.
case_images: fonc-12-878264-g002.jpg
case_images: PMC9193224_01_fonc-12-878264-g002.jpg
case_images: f2
case_images: Patient's Testosterone level. (A) The level of Testosterone change in each patient. The black line is the 2-week regimen; Red, green and blue are patients with 1H regimen. (B) Median changes of Testosterone levels in patients with 1H regimen. The black line is the 2-week regimen; The red line is the patients with 1h regimen; The yellow areas are interquartile spacing.
case_images: fonc-12-878264-g003.jpg
case_images: PMC9193224_01_fonc-12-878264-g003.jpg
case_images: f3